Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / SPONSORED ADR
-
Number of holders
-
868
-
Total 13F shares, excl. options
-
385M
-
Shares change
-
+2.71M
-
Total reported value, excl. options
-
$16.6B
-
Value change
-
+$150M
-
Put/Call ratio
-
0.41
-
Number of buys
-
407
-
Number of sells
-
-379
-
Price
-
$43.16
Significant Holders of GSK plc - SPONSORED ADR (GSK) as of Q3 2025
982 filings reported holding GSK - GSK plc - SPONSORED ADR as of Q3 2025.
GSK plc - SPONSORED ADR (GSK) has 868 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 385M shares
.
Largest 10 shareholders include Dodge & Cox (78.4M shares), FMR LLC (66.1M shares), Fisher Asset Management, LLC (32.2M shares), PRIMECAP MANAGEMENT CO/CA/ (25.8M shares), JTC Employer Solutions Trustee Ltd (14.6M shares), ROYAL BANK OF CANADA (8.82M shares), PRICE T ROWE ASSOCIATES INC /MD/ (7.95M shares), Holocene Advisors, LP (7.1M shares), STATE STREET CORP (6.62M shares), and GOLDMAN SACHS GROUP INC (6.52M shares).
This table shows the top 868 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.